Telephone
61.3.9215.9215
Address
Level 6 2125 Dandenong Road Clayton, Victoria (VIC) 3168
Description
Sigma Healthcare Ltd. engages in the manufacture and distribution of pharmaceutical products through pharmacy, grocery channels, and private labels. The firm's activities include wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies, including the provision of retail support services to the branded network of pharmacy members, dose administration aid services, technology and data analytics solutions to the customers. The company was founded on July 2, 1999 and is headquartered in Rowville, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 1.08 - 3.32
Trade Value (12mth)
AU$5,112,410.00
1 week
-3.21%
1 month
8.63%
YTD
12.69%
1 year
180.93%
All time high
3.32
EPS 3 yr Growth
-89.70%
EBITDA Margin
-1.30%
Operating Cashflow
$42m
Free Cash Flow Return
5.00%
ROIC
0.50%
Interest Coverage
-2.70
Quick Ratio
1.90
Shares on Issue (Fully Dilluted)
1858m
HALO Sector
Healthcare
Next Company Report Date
20-Mar-25
Ex Dividend Date (est.)
01-Oct-24
Next Dividend Pay Date (est.)
17-Oct-24
Reporting Currency
AUD
Short Sell (% of issue)
0.59
Date | Announcements |
---|---|
18 February 25 |
Appendix 3Y Change of Director's Interest Notice
×
Appendix 3Y Change of Director's Interest Notice |
18 February 25 |
Appendix 3Y Change of Director's Interest Notice
×
Appendix 3Y Change of Director's Interest Notice |
18 February 25 |
Application for quotation of securities - SIG
×
Application for quotation of securities - SIG |
18 February 25 |
Application for quotation of securities - SIG
×
Application for quotation of securities - SIG |
18 February 25 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
17 February 25 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
17 February 25 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
17 February 25 |
Final Director's Interest Notice
×
Final Director's Interest Notice |
14 February 25 |
Confirmation of Sigma's future financial reporting
×
Confirmation of Sigma's future financial reporting |
14 February 25 |
Ceasing to be a substantial holder from CGF
×
Ceasing to be a substantial holder from CGF |
14 February 25 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
14 February 25 |
Notification of cessation of securities - SIG
×
Notification of cessation of securities - SIG |
14 February 25 |
Application for quotation of securities - SIG
×
Application for quotation of securities - SIG |
14 February 25 |
Becoming a substantial holder
×
Becoming a substantial holder |
14 February 25 |
Becoming a substantial holder
×
Becoming a substantial holder |
14 February 25 |
Becoming a substantial holder
×
Becoming a substantial holder |
14 February 25 |
Form 603 Notice of Initial Substantial Holder
×
Form 603 Notice of Initial Substantial Holder |
13 February 25 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
13 February 25 |
Initial Director's Interest Notice
×
Initial Director's Interest Notice |
13 February 25 |
Initial Director's Interest Notice
×
Initial Director's Interest Notice |
13 February 25 |
Initial Director's Interest Notice
×
Initial Director's Interest Notice |
13 February 25 |
Initial Director's Interest Notice
×
Initial Director's Interest Notice |
13 February 25 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
12 February 25 |
Becoming a substantial holder
×
Becoming a substantial holder |
12 February 25 |
Application for quotation of securities - SIG
×
Application for quotation of securities - SIG |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.